Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tyler M Seibert

Showing results (71-80 of 132) with videos related to

Pageof 14
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 22, 2025
Urethra contours on MRI: Multidisciplinary consensus educational atlas and reference standard for artificial intelligence benchmarkingYuze Song, Lily Nguyen, Anna M Dornisch, et al.
Cancer|June 12, 2024
Healthy lifestyle and prostate cancer risk in the Million Veteran ProgramMeghana S Pagadala, Asona Lui, Julie Lynch, et al.
European Urology Oncology|August 4, 2024
Association Between the Decipher Genomic Classifier and Prostate Cancer Outcome in the Real-world SettingMichael S Leapman, Julian Ho, Yang Liu, et al.
Journal of the National Cancer Institute|October 28, 2022
Polygenic risk of any, metastatic, and fatal prostate cancer in the Million Veteran ProgramMeghana S Pagadala, Julie Lynch, Roshan Karunamuni, et al.
Journal of the National Cancer Institute|January 12, 2024
Genetic risk and likelihood of prostate cancer detection on first biopsy by ancestryKyung Min Lee, Tyler J Nelson, Alex Bryant, et al.
BJU International|March 28, 2026
Long-term outcomes of cribriform-positive and cribriform-negative prostate cancer treated with radical prostatectomy in the ProtecT trialNikita Sushentsev, Anne Y Warren, Richard Colling, et al.
Journal of Neuro-Oncology|September 15, 2017
Erratum to: Imaging correlates for the 2016 update on WHO classification of grade II/III gliomas: implications for IDH, 1p/19q and ATRX statusRachel L Delfanti, David E Piccioni, Jason Handwerker, et al.
Medrxiv : the Preprint Server for Health Sciences|July 3, 2023
Agent Orange exposure and prostate cancer risk in the Million Veteran ProgramAsona J Lui, Meghana S Pagadala, Allison Y Zhong, et al.
Scientific Reports|December 29, 2024
Utility of quantitative measurement of T<sub>2</sub> using restriction spectrum imaging for detection of clinically significant prostate cancerMariluz Rojo Domingo, Christopher C Conlin, Roshan Karunamuni, et al.
Practical Radiation Oncology|August 16, 2016
Distortion inherent to magnetic resonance imaging can lead to geometric miss in radiosurgery planningTyler M Seibert, Nathan S White, Gwe-Ya Kim, et al.
Pageof 14

Showing results (71-80 of 132) with videos related to

Sort By:
Pageof 14
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 22, 2025
Urethra contours on MRI: Multidisciplinary consensus educational atlas and reference standard for artificial intelligence benchmarkingYuze Song, Lily Nguyen, Anna M Dornisch, et al.
Cancer|June 12, 2024
Healthy lifestyle and prostate cancer risk in the Million Veteran ProgramMeghana S Pagadala, Asona Lui, Julie Lynch, et al.
European Urology Oncology|August 4, 2024
Association Between the Decipher Genomic Classifier and Prostate Cancer Outcome in the Real-world SettingMichael S Leapman, Julian Ho, Yang Liu, et al.
Journal of the National Cancer Institute|October 28, 2022
Polygenic risk of any, metastatic, and fatal prostate cancer in the Million Veteran ProgramMeghana S Pagadala, Julie Lynch, Roshan Karunamuni, et al.
Journal of the National Cancer Institute|January 12, 2024
Genetic risk and likelihood of prostate cancer detection on first biopsy by ancestryKyung Min Lee, Tyler J Nelson, Alex Bryant, et al.
BJU International|March 28, 2026
Long-term outcomes of cribriform-positive and cribriform-negative prostate cancer treated with radical prostatectomy in the ProtecT trialNikita Sushentsev, Anne Y Warren, Richard Colling, et al.
Journal of Neuro-Oncology|September 15, 2017
Erratum to: Imaging correlates for the 2016 update on WHO classification of grade II/III gliomas: implications for IDH, 1p/19q and ATRX statusRachel L Delfanti, David E Piccioni, Jason Handwerker, et al.
Medrxiv : the Preprint Server for Health Sciences|July 3, 2023
Agent Orange exposure and prostate cancer risk in the Million Veteran ProgramAsona J Lui, Meghana S Pagadala, Allison Y Zhong, et al.
Scientific Reports|December 29, 2024
Utility of quantitative measurement of T<sub>2</sub> using restriction spectrum imaging for detection of clinically significant prostate cancerMariluz Rojo Domingo, Christopher C Conlin, Roshan Karunamuni, et al.
Practical Radiation Oncology|August 16, 2016
Distortion inherent to magnetic resonance imaging can lead to geometric miss in radiosurgery planningTyler M Seibert, Nathan S White, Gwe-Ya Kim, et al.
Pageof 14